Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy Tags Diabetic Nephropathy Retinopathy Read more about Longstanding T2DM With Anemia Carries Greater Risk for Diabetic Retinopathy
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: Empagliflozin Shows Lower PE and DVT Risk vs Dapagliflozin
AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM Tags Hyperglycemia hyperosmolar state Long acting Read more about AACE 2026: Basal-Based Insulin Improves Inpatient Glycemic Control in T2DM
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM
AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin Tags SGLT-2 Inhibitor Read more about AACE 2026: LSM Declines Across Fibrosis Stages With Empagliflozin
AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss Tags hBA1c GLP-1 agonists Read more about AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss
Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis Tags GLP-1 agonists Read more about Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis
SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation Tags hBA1c SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation
Weekly Efsitora Achieves HbA1c <7% With Low Hypoglycemia Tags Hypoglycemia Long acting Read more about Weekly Efsitora Achieves HbA1c